BRAF and thyroid gland carcinoma: Fatty acid oxidation drives acetyl-CoA-dependent H3K9ac reprogramming to promote adaptive resistance to BRAF&lt;sup&gt;V600E&lt;/sup&gt; inhibition in thyroid cancer.